Menopause Hormone Therapy: What Women Should Know About Benefits, Risks & Options
- Stephanie Martinez, FNP-C, MSCP
- Aug 9
- 6 min read
Hormone therapy has had a complicated reputation.
Some women have been told it is dangerous. Others see social media posts suggesting nearly every woman should be taking estrogen, progesterone, and testosterone.
Neither extreme tells the whole story.
Menopausal hormone therapy can be highly effective for appropriately selected women- but it is not a one-size-fits-all treatment.
Understanding what hormone therapy can treat, the different types available, and how individual health factors affect its risks and benefits can help you have a more informed conversation about whether it may be appropriate for you.
What Is Menopausal Hormone Therapy?
Menopausal hormone therapy, often abbreviated MHT, involves using hormones to treat certain symptoms associated with the menopause transition.
Estrogen is the primary hormone used to treat common menopausal symptoms such as hot flashes and night sweats.
For women who still have a uterus, systemic estrogen is generally combined with adequate progesterone or another progestogen to protect the lining of the uterus.
Hormone therapy can be individualized based on your symptoms, whether you have a uterus, medical history, preferences, and treatment goals.
Do I Have to Wait Until Menopause to Use Hormone Therapy?
No.
This is an important misconception.
You do not necessarily have to stop having periods before menopausal hormone therapy can be considered.
Women experiencing bothersome symptoms during perimenopause may be candidates for treatment depending on their individual circumstances.
Because ovulation and pregnancy can still occur during perimenopause, contraception is a separate consideration. Menopausal hormone therapy itself should not be assumed to provide reliable contraception.
Treatment decisions should be based on the entire clinical picture—not simply whether you've had your “last period” yet.
What Symptoms Can Hormone Therapy Treat?
Systemic estrogen therapy is the most effective treatment for bothersome vasomotor symptoms, including:
Hot flashes
Night sweats
Hormone therapy may also improve associated sleep disruption when vasomotor symptoms are contributing to nighttime awakenings.
Systemic estrogen also helps prevent bone loss while it is being used and may be considered for prevention of osteoporosis in appropriately selected women.
For women whose primary symptoms involve vaginal dryness, painful sex, or certain urinary symptoms, low-dose vaginal estrogen or other local therapies may be more appropriate than systemic treatment.
The treatment should match the symptoms we're trying to address.
Estrogen Isn't Just One Medication
When someone says she's “taking estrogen,” that doesn't tell you very much.
Estrogen therapy is available in several forms, including:
Transdermal patches
Gels
Sprays
Oral tablets
Vaginal creams
Vaginal tablets or inserts
Vaginal rings
These products are not necessarily interchangeable.
For systemic treatment, the route of administration may matter when considering an individual's health history and risk factors.
For example, transdermal estrogen- which is absorbed through the skin- avoids first-pass metabolism through the liver and may be preferred in some clinical situations.
The best route depends on the individual woman.
Why Is Progesterone Sometimes Needed?
If you have a uterus and use systemic estrogen, the endometrium- the lining of the uterus- must generally be protected.
Estrogen stimulates the endometrium. Using systemic estrogen without adequate progestogen protection can increase the risk of endometrial hyperplasia and endometrial cancer.
Progesterone or another progestogen is therefore generally prescribed along with systemic estrogen for women with an intact uterus.
The regimen may be continuous or cyclic depending on the clinical situation.
Women who have had a hysterectomy generally do not need a progestogen solely for endometrial protection.
What Does “Bioidentical” Actually Mean?
The term “bioidentical” can be confusing. Bioidentical simply means that a hormone has the same chemical and molecular structure as a hormone naturally produced by the human body.
Both FDA-approved and compounded hormone therapies can contain bioidentical hormones. For example, estradiol and micronized progesterone are available in FDA-approved formulations, while compounding pharmacies can also prepare individualized formulations containing these hormones.
Compounded hormone therapy may allow for customization of dosage forms, strengths, or combinations that are not commercially available. However, compounded medications do not undergo the same FDA approval process as commercially manufactured medications, and quality and consistency depend on appropriate compounding standards and pharmacy practices.
The choice between commercially available and compounded hormone therapy should be individualized rather than based on the assumption that one is automatically more “natural,” safer, or more effective than the other.
At Prime Optimal Health, treatment recommendations consider your symptoms, medical history, treatment goals, preferences, medication availability, and the formulation and route that are appropriate for your individual situation.
Do I Need Hormone Levels Checked Before Starting?
Usually, hormone therapy for typical menopausal symptoms in women over 45 is not determined by finding a single “optimal” estrogen level.
During perimenopause, reproductive hormones can fluctuate substantially from day to day and throughout the menstrual cycle.
A normal estradiol or FSH result therefore does not necessarily exclude perimenopause.
Likewise, treatment generally isn't about chasing a laboratory number.
Laboratory evaluation may be appropriate when the diagnosis is uncertain, symptoms are atypical, another medical condition is suspected, or the clinical situation warrants additional testing.
Symptoms, menstrual history, age, medical history, and treatment goals often tell us more than a random hormone level.
Is Hormone Therapy Safe?
This deserves more nuance than either “yes” or “no.”
For many healthy women who are younger than 60 or within approximately 10 years of menopause onset and who do not have contraindications, the benefit-risk profile of hormone therapy for bothersome menopausal symptoms is generally considered favorable.
But individual risk matters.
A healthcare provider should consider factors such as:
Personal and family medical history
Age and time since menopause
Cardiovascular risk
History of blood clots
Breast health and cancer history
Unexplained vaginal bleeding
Liver disease
Migraine history
Other medications and medical conditions
The type, dose, route, and duration of hormone therapy can also influence the risk-benefit discussion.
What About Breast Cancer?
This is understandably one of the biggest concerns women have about hormone therapy.
The relationship between hormone therapy and breast cancer depends on factors including which hormones are used and how long therapy is continued.
Evidence from major trials suggests that estrogen therapy alone and combined estrogen-progestogen therapy do not have identical breast-risk profiles.
That is one reason broad statements such as “HRT causes breast cancer” fail to capture the actual evidence.
Your personal breast history, family history, screening history, and other risk factors should be considered as part of an individualized discussion.
Hormone therapy isn't risk-free.
But the risks should be discussed accurately and in context.
What About Blood Clots and Stroke?
Systemic hormone therapy can influence the risk of venous thromboembolism and stroke.
Risk varies according to factors such as age, underlying health, dose, and potentially the route of estrogen administration.
Evidence suggests that transdermal estrogen may have a lower risk of venous thromboembolism than oral estrogen, although treatment still needs to be individualized.
This is one reason the route of therapy matters rather than treating every estrogen prescription as equivalent.
Is There a Specific Age When I Have to Stop Hormone Therapy?
Not necessarily.
There is no universal rule that every woman must automatically discontinue hormone therapy at age 60 or 65.
Whether treatment should continue depends on ongoing symptoms, treatment goals, health history, risks, benefits, and patient preference.
For some women, continuing therapy beyond those ages may be reasonable after appropriate counseling and periodic reassessment.
The decision should be individualized rather than dictated by a birthday.
What About Testosterone?
Testosterone deserves its own conversation.
It is sometimes marketed broadly to women for fatigue, weight loss, mood, cognition, muscle building, or “hormone optimization.”
The evidence is much narrower than that marketing suggests.
The best-supported indication for systemic testosterone therapy in appropriately selected postmenopausal women is hypoactive sexual desire disorder (HSDD) after appropriate biopsychosocial evaluation.
Testosterone is not currently recommended as a universal component of menopausal hormone therapy.
And because this deserves more than one paragraph, we'll cover testosterone specifically in another article.
Hormone Therapy Should Have a Purpose
The goal of hormone therapy should not simply be to make laboratory numbers look “optimal.”
We should be able to answer:
What symptoms or health concerns are we treating?
Then we can determine whether hormone therapy is appropriate, which therapy makes sense, and whether it's actually helping.
Treatment should also be periodically reassessed as symptoms, health history, and goals change.
Menopause Care at Prime Optimal Health
At Prime Optimal Health, menopausal hormone therapy is considered within the context of your symptoms, menstrual and reproductive history, medical history, medications, health risks, preferences, and treatment goals.
Recommendations may include lifestyle strategies, nonhormonal treatment options, local vaginal therapy, systemic menopausal hormone therapy when clinically appropriate, additional evaluation, or a combination of approaches.
Treatment is individualized based on your symptoms, health history, preferences, and treatment goals rather than focused solely on achieving a predetermined hormone level.
The goal isn't to put every woman on hormones- or keep every woman off them. It's to help you understand the evidence, your individual risks and potential benefits, and the options available to you.
Ready to Learn More?
If you're experiencing symptoms of perimenopause or menopause and wondering whether hormone therapy may be appropriate for you, a Comprehensive Midlife Consultation provides time for an individualized evaluation and discussion of your treatment options.
References & Resources
Medical Disclaimer
This article is intended for general educational and informational purposes only and does not constitute medical advice, diagnosis, or treatment. The information provided is not a substitute for individualized medical care. Always consult with a qualified healthcare professional regarding your individual health concerns and before starting, stopping, or changing any treatment or medication.
Last updated: August 2026
Comments